Guide to Medicinal Plants · Anthroposophic medicine in context

Anthroposophic Medicinal Plants: What Lies Behind Mistletoe, Arnica and More

Anthroposophic medicines sit somewhere between herbal medicine, homeopathy and a distinct view of the human being. I put into context for you what the studies on mistletoe, arnica and bryophyllum have to offer. And where evidence ends and experience begins.

Mistletoe Arnica Bryophyllum Calendula Medicinal Products Act Evidence check
Shukri Jarmoukli · Physician, Integrative Medicine · ViveCura Berlin
My starting point

In my practice, anthroposophic medicines are among the tools I use deliberately. That is exactly why I want to know precisely where they hold up and where they do not. Respecting a tradition does not mean following it blindly. And scientific honesty does not mean belittling it.

Maybe there was always an ointment with the yellow arnica flower in the cupboard at home. Maybe someone recommended a herbal remedy with a hard-to-pronounce name for restless nights. Or, after a serious diagnosis, you heard the words mistletoe therapy for the first time.

Somewhere inside you, a question then takes hold: is this medicine, a worldview or both?

The answers often come from two camps. One side says: it is all placebo. The other says: something is happening here that studies simply cannot capture. Both statements are convenient, and both make things too easy.

Behind your question lies a need I understand well. You want to do something good for yourself without being naive. That is why I am not offering you a camp, but a map.

To do this, I look through several lenses: clinical studies, the German S3 guideline on complementary medicine in cancer care, the German Medicinal Products Act and KPNI. KPNI stands for Clinical Psychoneuroimmunology, the interplay of nerves, immune system, hormones and metabolism.

What to expect here

  • What makes a medicine anthroposophic in the first place
  • Marketing authorisation, registration and Commission C, clearly explained
  • Mistletoe in cancer: what studies and the S3 guideline say
  • Arnica: why gel and globules are two different questions
  • Bryophyllum and calendula: experience meets small studies
  • How safe anthroposophic medicines are according to current data
  • Where evidence ends and experience begins
  • Three levers for an informed decision
1920sthe decade in which Rudolf Steiner and Ita Wegman founded anthroposophic medicine
290people in the double-blind MISTRAL trial on mistletoe in advanced pancreatic cancer
204people with finger osteoarthritis in a trial comparing arnica gel with ibuprofen gel
Evidence markers: Clinical trial or meta-analysis In humans: observation, review Animal study Laboratory: cells, tissue

What is anthroposophic medicine, and what makes a medicine anthroposophic?

The word sounds like philosophy, like Waldorf schools, like Rudolf Steiner. That is exactly what unsettles many people. Is this even medicine?

Short answer: anthroposophic medicine was founded in the early 1920s by Rudolf Steiner and Ita Wegman. It sees itself as an integrative system that complements conventional medicine. Its medicines come from plants, minerals and animals, and some of them are potentised. The German Medicinal Products Act defines them by how they are developed, manufactured and used, not by proof of efficacy.

A view of the human being as the starting point

A team led by Kienle from Witten/Herdecke University describes anthroposophic medicine as a multimodal system. It includes medicines, art therapy, eurythmy therapy, rhythmical massage, counselling and special nursing techniques such as therapeutic rubs. According to the team, it is practised in around 80 countries, most widely in Central Europe.

At its centre is a view of the human being with four levels of formative forces and a threefold constitution. You do not have to share this view to follow this article. But it explains why, alongside the diagnosis, a person's constitution and rhythms are also considered.

Incidentally, one idea from it also runs through this blog. The threefold division into thinking, feeling and willing is reflected in the triad I build every section around: feel, understand, act.

What makes a remedy anthroposophic

In Section 4(33), the German Medicinal Products Act describes an anthroposophic medicinal product by three features. It was developed according to the anthroposophic understanding of the human being and nature. It was manufactured using a homeopathic or a special anthroposophic procedure. And it is intended to be used according to these principles.

In practice, this means that very different medicines can be made from the same plant. A plant extract as a gel. A fermented extract for injection. Or a potency, that is, a preparation diluted step by step.

A D6 corresponds to a dilution of one to a million. Imagine one millilitre spread across one cubic metre of water, which is about five full bathtubs. Such remedies are manufactured according to rulebooks such as the German Homeopathic Pharmacopoeia or the Anthroposophic Pharmaceutical Codex.

A lot of research, of varying strength

Study · 265 studies of very mixed quality HTA review

In 2011, following a Swiss referendum on complementary medicine, a team led by Kienle updated an assessment report on anthroposophic medicine.

They found 265 clinical studies, including 38 randomised studies and 142 without a control group. As many as 133 of them examined mistletoe in cancer. Most reported positive results, but methodological quality varied considerably.

What this means for you: there is a lot of research. But a lot of research is not the same as strong research.

Kienle GS, Glockmann A, Grugel R, Hamre HJ, Kiene H. Forsch Komplementmed. 2011;18(5):269-82. DOI: 10.1159/000331812

A view from outside is more sober. In 2004, Ernst from the Peninsula Medical School in Exeter searched for randomised trials testing anthroposophic medicine as a whole system. He did not find a single one that met his criteria. He had deliberately excluded studies on individual remedies, and those are exactly what the rest of this article is about.

A change of perspective

Anthroposophic first of all describes a way of thinking and of manufacturing. It is neither a seal of quality nor a warning label.

So the crucial question is not: are you for or against anthroposophy? It is: which remedy, in which form, for what, and what do we know about it?

If someone recommends an anthroposophic remedy to you, ask about the form first: plant extract, potency or injection? This one question already sorts out a lot.

And now you know why the word anthroposophic on its own tells you nothing yet about whether a remedy works.

How does the German Medicinal Products Act classify anthroposophic medicines?

You turn a pack over and read: without stating a therapeutic indication. This is where many people pause. So what is the remedy for, then?

Short answer: in Germany, anthroposophic medicine has been classed as a special therapeutic system since the Medicinal Products Act of 1976, alongside homeopathy and phytotherapy. Its remedies reach the pharmacy by two routes. With a marketing authorisation, which requires proof of efficacy and takes the experience of the therapeutic system into account. Or with a registration, for which neither indications nor clinical trials have to be submitted.

Two doors into the pharmacy

Imagine two doors. Behind the first, efficacy is assessed. Behind the second, nobody asks about efficacy.

The first door is the marketing authorisation. Under Section 25 of the Medicinal Products Act, it is refused if the stated therapeutic efficacy is lacking or insufficiently substantiated. However, it may not be refused solely because results were achieved in only a limited number of cases. And under Section 22, the medical experience of the therapeutic system concerned must explicitly be taken into account.

The second door is registration. It is open to remedies manufactured using homeopathic procedures, and the law explicitly includes anthroposophic remedies here. The application does not have to contain any information on effects or indications, nor any clinical trials. One requirement is that the use of the active substances as a homeopathic or anthroposophic medicine is generally known.

The pack of such a remedy then carries the sentence that may have puzzled you: “Registriertes homöopathisches Arzneimittel, daher ohne Angabe einer therapeutischen Indikation”, which means registered homeopathic medicinal product, therefore without stating a therapeutic indication. Section 10 of the Act prescribes this for remedies in the register of homeopathic medicinal products.

Commission C: expertise from within the therapeutic system

Germany's Federal Institute for Drugs and Medical Devices has its own expert commissions for the special therapeutic systems. Commission C is responsible for anthroposophic medicines, Commission D for homeopathic and Commission E for herbal ones. Under the Medicinal Products Act, the responsible commission is involved in certain decisions. In this way, expertise from each system feeds into the authority's work.

Two readings of the same rule

You can read these rules as respect for other ways of gaining knowledge. You can also criticise them as a special path, because the same standards do not apply everywhere.

For you, one thing matters above all: a marketing authorisation within this therapeutic system does not automatically mean that efficacy has been shown in large, blinded trials. A registration means that efficacy has not been assessed at all.

A change of perspective

“Without stating an indication” does not mean ineffective. Nor does it mean effective. It means: this question has not been officially assessed.

The gap is then filled by your doctor or pharmacy, with experience, with literature and, hopefully, with honesty about what is not known.

Next time, take a look at the pack: does it state an indication, or the note on registration? And ask whether it is a plant extract or a potency.

And now you know why two preparations from the same plant can be two entirely different things in legal terms.

What does research show on mistletoe therapy in cancer?

After a cancer diagnosis, many people want to do something themselves. Not just keep appointments, but actively shape their care. Often, one word then comes up: mistletoe.

Important upfront

Mistletoe therapy is not a cancer treatment and does not replace surgery, chemotherapy, radiotherapy, hormone therapy or immunotherapy. If anything, it is a complementary use alongside your treatment. Please decide on it only together with your treating oncologist. This section puts the evidence into context and is not a recommendation for or against mistletoe therapy in your situation.

Short answer: mistletoe is the most extensively studied anthroposophic medicinal plant. There is no robust evidence of longer survival, and the S3 guideline makes no recommendation either for or against it on this point. On quality of life, the data are contradictory. With quality of life as the goal, the guideline says subcutaneous administration may be considered in solid tumours. A large double-blind trial with 290 people, by contrast, found no benefit.

An approach rooted in anthroposophy

Mistletoe therapy for people with cancer has its origins in anthroposophic medicine. Today, it is one of the most frequently prescribed complementary therapies in cancer care in Central Europe. A whole extract of mistletoe is injected under the skin, fermented or non-fermented depending on the manufacturer.

Through the KPNI lens, mistletoe is above all a stimulus for the immune system. Redness often appears at the injection site, and sometimes body temperature rises slightly. Researchers from Berlin interpret such reactions as an expected consequence of mistletoe's immune-stimulating properties.

This is where a very human error in reasoning is tempting. If the body reacts visibly, something must surely be happening. Yes, something is happening. But a reaction is not yet a benefit.

What the major reviews say

Study · The Cochrane review 21 RCTs, n=3,484

For the Cochrane Collaboration, a team led by Horneber from Klinikum Nürnberg analysed 21 randomised trials with a total of 3,484 people with cancer.

Of 13 trials on survival, 6 showed signs of a benefit, none of them of high methodological quality. For quality of life, there were signs of a benefit, but at higher quality only in two trials in breast cancer during chemotherapy.

What this means for you: the team called the evidence for longer survival weak. The signs regarding quality of life would first need to be confirmed.

Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Cochrane Database Syst Rev. 2008;(2):CD003297. DOI: 10.1002/14651858.CD003297.pub2

A research group led by Ernst had already arrived at a similar picture in 2003. Among ten randomised trials, it was mainly the methodologically weaker ones that pointed to a benefit, especially for quality of life. None of the methodologically stronger trials showed efficacy, neither for quality of life nor for survival.

Two reviews, two readings

It gets interesting when you put more recent reviews side by side. They draw on a similar body of studies and still reach opposite conclusions.

Jena, 2019 Systematic review

A team led by Freuding and Huebner from Jena University Hospital found that studies with better methodology show less or no effect on quality of life. For survival, most studies showed no effect, the high-quality ones in particular. Their conclusion: no reason to prescribe mistletoe.

Berlin, 2020 Meta-analysis

Loef and Walach from the CHS Institute in Berlin calculated a medium-sized effect on global quality of life from 26 publications. According to their analysis, it was even stronger in randomised and blinded studies. However, most of the studies had a high risk of bias or gave cause for concern.

How can that be? Anyone who selects, weights and rates studies makes many small decisions. Each of them can shift the result. On top of that comes a problem that weighs particularly heavily with mistletoe: blinding.

Imagine a taste test in which one variety clearly fizzes. Anyone tasting it quickly guesses what is in the glass. With mistletoe, the reddened injection site is that fizz.

The trial that wanted to know for sure

An open-label trial from Serbia had reported better quality of life with mistletoe in advanced pancreatic cancer.

Study · Mistletoe in advanced pancreatic cancer RCT, open-label, n=220

A team led by Tröger studied 220 people who were no longer receiving any cancer treatment apart from best supportive care. They received either mistletoe extract or no additional treatment.

The mistletoe group scored better on all six functional scales and on seven of nine symptom scales, for example for pain, fatigue and appetite. The trial was open-label, without placebo, and was stopped early after an interim analysis that suggested longer survival.

What this means for you: a promising signal. Without placebo, however, it remains open what mistletoe contributed and what expectation and additional attention might have contributed.

Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M. Dtsch Arztebl Int. 2014;111(29-30):493-502. DOI: 10.3238/arztebl.2014.0493

A Swedish team wanted to test exactly this hope with the gold standard of clinical research: double-blind and with placebo. It is worth noting who took part. The authors also included Kienle from the Freiburg Center for Complementary Medicine, who has herself been publishing on anthroposophic medicine for years.

Study · MISTRAL: double-blind against placebo RCT, double-blind, n=290

At Swedish cancer centres, a team led by Wode from Umeå University randomly assigned 290 people with advanced pancreatic cancer to two groups. In addition to standard treatment, they received mistletoe extract or a placebo under the skin for nine months.

There was no benefit for survival or for global quality of life. Median survival was 7.8 months with mistletoe and 8.3 months with placebo. Skin reactions at the injection site occurred in 66 percent of the mistletoe group and 1 percent of the placebo group.

What this means for you: under strict conditions, the hoped-for benefit could not be confirmed in this situation.

Wode K, Kienle GS, Björ O, et al. Dtsch Arztebl Int. 2024;121(11):347-354. DOI: 10.3238/arztebl.m2024.0080

In 2026, the team followed up with the detailed analysis of quality of life. Here too, there were no differences, neither in quality of life nor in body weight. In the blood, only the eosinophilic granulocytes, a group of white blood cells, rose with mistletoe, without any link to a clinical effect. The researchers write that there is no clinical reason to recommend mistletoe extract in advanced pancreatic cancer.

A change of perspective

This trial is not a victory of one side over the other. It is an example of what good research looks like: people test a hope as rigorously as possible and publish the result even when it shows no benefit.

It applies to one specific type of cancer at an advanced stage. Whether the result can be transferred to other situations is a question it does not answer.

And survival?

This is where the analyses diverge most widely. A meta-analysis from Witten/Herdecke on the fermented mistletoe preparation Iscador reached a positive result, but it rests exclusively on non-blinded studies. A Berlin meta-analysis on non-fermented preparations also found signs of a benefit. As soon as studies with active comparison treatments were included, it was no longer significant.

The Jena review, by contrast, found no effect on survival in most studies, especially not in the high-quality ones. And MISTRAL, the double-blind trial, saw no difference.

What the S3 guideline says

On survival: the results from reviews and individual studies are partly positive and partly without a statistically significant effect. They are not sufficient for a final assessment. The guideline therefore makes no recommendation for or against mistletoe preparations with the aim of longer survival.

On quality of life: subcutaneous administration of whole mistletoe extract may be considered for therapeutic use to improve quality of life in patients with solid tumours. This is recommendation grade 0, an open “may” recommendation.

S3 guideline Complementary Medicine in the Treatment of Oncological Patients (Komplementärmedizin in der Behandlung von onkologischen PatientInnen), version 2.0, May 2024. The mistletoe chapter was not among the chapters newly researched for this update. The MISTRAL results are therefore probably not yet taken into account in it.

How well tolerated is mistletoe?

Study · Side effects in everyday practice Observational, n=1,923

A team led by Steele from the Havelhöhe Research Institute in Berlin analysed data from 1,923 people with cancer who received mistletoe extract under the skin.

Expected reactions such as small areas of redness at the injection site or a slightly raised temperature occurred in 14.7 percent. The team documented adverse drug reactions in 8.4 percent, mostly mild to moderate and none of them serious. They became more frequent at higher doses.

What this means for you: in these data, mistletoe appears to be well tolerated. However, the study comes from an anthroposophic hospital setting and had no comparison group.

Steele ML, Axtner J, Happe A, Kröz M, Matthes H, Schad F. Evid Based Complement Alternat Med. 2014;2014:724258. DOI: 10.1155/2014/724258

Rare but serious reactions do still occur. A case report from the university dermatology clinic in Freiburg describes grade II anaphylaxis, a whole-body allergic reaction, after a mistletoe injection. So if you have shortness of breath, circulatory problems, a widespread rash or swelling of the face: call the emergency number 112 immediately.

If you are considering mistletoe therapy, take the question to your oncology team. Ask about the goal, about possible interactions with your current treatment, and about how you would recognise together whether it is doing you good.

And now you know why mistletoe is not a yes-or-no topic, but a weighing-up that belongs in oncological hands.

Arnica as a gel or as globules: what do the studies show?

You bump into the edge of the table, and someone is already reaching for the arnica. For many people, it is the household remedy par excellence. But not all arnica is the same.

Short answer: as a gel made from arnica tincture, arnica performed similarly to an ibuprofen gel for finger osteoarthritis in a study with 204 people. The European Medicines Agency classifies arnica flowers for external use in bruises, sprains and localised muscle pain as a traditional medicinal product. For potentised arnica, reviews show no established effect beyond placebo.

The plant in the tube

Arnica, botanically Arnica montana, belongs to the daisy family. Its flowers contain sesquiterpene lactones, a group of chemically reactive plant compounds.

Study · An inflammation switch in the lab Cell experimentsMouse

A team led by Klaas and Merfort from the University of Freiburg tested preparations made from arnica flowers on immune cells and in an inflammation test on the mouse ear.

The preparations slowed the activation of NF-kappaB, a central inflammation switch. The more sesquiterpene lactones they contained, the stronger this effect was.

What this means for you: there is a plausible mechanism for external arnica. In humans, it has not been directly demonstrated in this form.

Klaas CA, Wagner G, Laufer S, et al. Planta Med. 2002;68(5):385-91. DOI: 10.1055/s-2002-32067

In 1998, a Freiburg research group led by Lyss had shown how this might work. In cell cultures, the related substance helenalin directly altered one component of this switch, the p65 subunit. Imagine chewing gum in a light switch: it sticks, no matter how often someone presses it.

Study · Arnica gel versus ibuprofen gel RCT, double-blind, n=204

A team led by Widrig from St. Gallen treated 204 people with osteoarthritis of the finger joints for three weeks with either a gel made from arnica tincture or a gel containing five percent ibuprofen.

There were no differences between the groups in pain or hand function. Adverse events were reported by 4.8 percent with arnica and 6.1 percent with ibuprofen.

What this means for you: for finger osteoarthritis, an arnica gel could be an alternative to a pain-relief gel. It was not tested against a placebo in this study.

Widrig R, Suter A, Saller R, Melzer J. Rheumatol Int. 2007;27(6):585-91. DOI: 10.1007/s00296-007-0304-y

The Cochrane review by Cameron and Chrubasik rates this study as moderate-quality evidence. According to the review, arnica gel probably eases symptoms about as well as an ibuprofen gel. On side effects, however, it did no better, and possibly even slightly worse.

The plant as a potency

Potentised arnica, for example as globules, is a different question. Most studies on it come from homeopathy, whose potencies are manufactured using procedures similar to those for anthroposophic potencies.

In 1998, Ernst and Pittler from the University of Exeter found eight placebo-controlled trials. Most had serious methodological flaws. Overall, they did not suggest that homeopathic arnica does more than a placebo.

Study · Arnica potencies around surgery Meta-analysis

In 2021, a team led by Gaertner from the Institute of Integrative Medicine at Witten/Herdecke University analysed studies on homeopathic arnica in surgery.

In the placebo-controlled comparisons, there was a small effect that narrowly missed statistical significance. The larger effect compared with active comparators came mainly from non-randomised studies and shrank towards zero in the randomised ones.

What this means for you: the team interprets the result as a small effect, comparable to that of anti-inflammatory drugs. I read it more cautiously, as an uncertain signal.

Gaertner K, Baumgartner S, Walach H. Front Surg. 2021;8:680930. DOI: 10.3389/fsurg.2021.680930

The mechanism shown in the lab depended on the amount of sesquiterpene lactones. In a D6, this amount is diluted by a factor of one million. Whether enough is then left to measurably slow the inflammation switch is questionable. A scientifically established mechanism for high potencies has not been described so far.

One point that applies to every arnica on the skin

One issue affects every arnica applied to the skin: allergies. A review from the Danish allergy research centre counts the daisy family among the important triggers of allergic contact eczema in Europe. According to the review, sensitisation to arnica is relatively common. The European Medicines Agency lists itching, redness and eczema as possible side effects.

A change of perspective

The same plant, two worlds. The question is not: arnica, yes or no? It is: which arnica, for what, and with which expectation?

A gel brings measurable plant compounds onto the skin. A potency follows a different logic, which has not so far shown up in robust study results.

For a bruise or sprain, an arnica preparation for the skin can be an option for a few days. The European Medicines Agency provides for use from the age of twelve. If symptoms last longer than three to four days or get worse, it recommends medical advice. Severe pain, marked swelling or a suspected fracture should be checked by a doctor in any case.

What other plants show for joint pain is covered in Turmeric for osteoarthritis. Why movement remains the foundation is explained in Exercise for osteoarthritis.

And now you know why arnica is not a matter of belief, but a question of which form you are holding in your hand.

Bryophyllum and calendula: what lies behind the classics?

It is two in the morning. Your body is tired, your head is not. For nights like these, anthroposophic medicine often uses a remedy made from a plant whose name hardly anyone can pronounce fluently.

Short answer: bryophyllum comes from Madagascar and has been used in anthroposophic medicine since the early 20th century, for example for restlessness and sleep problems. The studies on it are small and mostly without a control group, and a small placebo-controlled trial showed only a trend in overactive bladder. For calendula, two randomised trials on the skin during radiotherapy contradict each other.

A succulent from Madagascar

Bryophyllum pinnatum, also called Kalanchoe pinnata, is a succulent from Madagascar. In 2016, a team led by Fürer and Potterat from the University of Basel summarised what it is used for in anthroposophic medicine. These are so-called states of overactivity such as restlessness, sleep disorders and preterm labour.

The team also points to bufadienolides in the plant, substances that can be potentially toxic. That is one reason why even a herbal remedy belongs in expert hands.

Study · Sleep during cancer Observational, n=20

At the Paracelsus Hospital Richterswil, a team led by Simões-Wüst followed people with cancer and sleep problems who received bryophyllum tablets. Of 28 participants, 20 provided complete data.

After three weeks, the score on the Pittsburgh Sleep Quality Index fell from 12.2 to 9.1 points, where a lower score means better sleep. Fatigue did not change, and no serious side effects occurred.

What this means for you: a signal, nothing more. Without a comparison group, it remains open how much of this is due to the remedy, and the researchers themselves call for randomised trials.

Simões-Wüst AP, Hassani TA, Müller-Hübenthal B, et al. Integr Cancer Ther. 2015;14(5):452-9. DOI: 10.1177/1534735415580680

The S3 guideline on complementary medicine considers the data on bryophyllum for fatigue and sleep disorders in cancer patients insufficient. It therefore makes no recommendation for or against it.

Study · Overactive bladder RCT, double-blind, n=20

A team led by Betschart from University Hospital Zurich gave 20 postmenopausal women with overactive bladder either bryophyllum or a placebo for eight weeks.

The number of trips to the toilet per day fell from 9.5 to 7.8 with bryophyllum and from 9.3 to 9.1 with placebo. The difference narrowly missed statistical significance, and quality of life improved similarly in both groups.

What this means for you: a trend in a very small study. That is not enough for a recommendation.

Betschart C, von Mandach U, Seifert B, et al. Phytomedicine. 2013;20(3-4):351-8. DOI: 10.1016/j.phymed.2012.10.007

In the lab, it gets even more complicated. On muscle strips from pig bladders, the pressed juice of the leaves actually strengthened muscle contraction. Individual fractions containing bufadienolides or flavonoid building blocks, on the other hand, weakened it. So the plant is not a single active ingredient but a mixture whose components can pull in different directions.

Bryophyllum has also been tested in obstetrics. Two randomised trials in Switzerland on suppressing preterm contractions were stopped early, so hardly any robust conclusion about efficacy can be drawn from them. Preterm labour always belongs in medical hands, ideally directly in a maternity hospital.

Calendula: two studies, two results

Pot marigold, or calendula, is a skincare classic. In a Berlin study in the practices of anthroposophic doctors, it was among the most frequently prescribed daisy-family remedies, alongside chamomile and arnica. Among other things, it has been studied for skin irritation from radiotherapy after breast cancer surgery.

Lyon, 2004 RCT, n=254

A team led by Pommier compared a calendula ointment with the skin product trolamine in 254 people undergoing radiotherapy. Skin inflammation of grade 2 or higher occurred in 41 percent with calendula and in 63 percent with trolamine.

Stockholm, 2013 RCT, n=420

In a blinded comparison, a team led by Sharp compared a calendula cream with a simple aqueous cream. More severe skin reactions occurred in 23 and 19 percent, with no difference between the groups.

The first study used a comparison product whose own benefit for this purpose had not been demonstrated. The second, blinded study found no difference from a plain cream. Calendula can be a pleasant skincare product. Whether it protects the skin during radiotherapy better than a simple cream remains open on the basis of these data.

A change of perspective

A long tradition and good tolerability are valuable. But they are a different kind of information from proof in a fair comparison.

With bryophyllum and calendula, we are at exactly this point: a lot of experience, interesting signals, too few good studies.

With sleep problems, it is worth looking at the basics first. You can find ideas in 4-7-8 breathing for falling asleep and in Valerian and passionflower for sleep disorders.

And now you know why a classic from the home medicine cabinet does not necessarily have solid evidence behind it.

How safe are anthroposophic medicines?

Natural means harmless, right? Many people think so, especially with globules and ointments. It is not quite that simple.

Short answer: in large analyses from Germany, side effects were rare and serious side effects very rare. Among doctors with complete documentation, a side effect occurred in 0.071 percent of prescriptions. Injections stand out more often than tablets or ointments, and daisy-family plants such as arnica and calendula can trigger allergies.

Study · 311,731 prescriptions Pharmacovigilance, n=44,662

In the EvaMed network, a team led by Hamre analysed the treatment data of 44,662 people treated by 38 doctors in Germany. The analysis covered 311,731 prescriptions of 1,722 different anthroposophic medicines from 2001 to 2010.

Among seven doctors who also documented mild reactions, side effects occurred in 0.071 percent of prescriptions. Overall, there was a single serious side effect.

What this means for you: most anthroposophic remedies appear to be well tolerated. However, doctors' documentation can miss things that patients do not report.

Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Drugs Real World Outcomes. 2017;4(4):199-213. DOI: 10.1007/s40801-017-0118-5

A second analysis led by Jong used the reporting databases of four manufacturers from 2010 to 2017. Reported side effects were rare overall, but clearly more frequent after injections than after tablets or external remedies. Inflammation at the injection site was reported most often. The researchers themselves stress that such spontaneous reports cannot be compared directly with study data.

There are separate data for the daisy family. In the Berlin study led by Jeschke, 18,830 people received remedies containing daisy-family extracts, most often chamomile, calendula and arnica. No serious side effects were reported for them. Still, an allergy to the daisy family remains a point you should know about, including with echinacea.

Honesty requires one more point. The large safety analyses come mainly from research institutions close to anthroposophic medicine. That does not make them worthless. Independent data would still be desirable.

Particular caution makes sense if you
  • have cancer. Mistletoe and other remedies should then be agreed with your oncology team.
  • are pregnant or breastfeeding. I found hardly any systematic safety studies for the remedies discussed here.
  • are allergic to the daisy family, for example to chamomile, arnica or marigold.
  • are due to receive a remedy by injection. Injections stand out more often in the reporting data.
  • want to treat children. The European monograph provides for arnica flowers only from the age of twelve.
A change of perspective

Well tolerated and effective are two different questions. A remedy can be very safe and still do little. Another can have an effect and carry risks precisely because of that.

And now you know why natural means neither automatically harmless nor automatically dangerous.

Where does evidence end, and where does experience begin?

Maybe you are thinking now: but the globules did me good. Or: my mother swears by her mistletoe therapy. These experiences are real. The only question is what exactly they show.

Short answer: evidence answers whether a remedy does more than placebo or another treatment in a fair comparison. Experience answers how a person fares with it. Both are valuable, but not interchangeable. According to current research, placebo effects are real psychobiological processes that arise from the entire treatment context.

Study · When the context is part of the treatment Review

In 2010, a team led by Finniss and Benedetti summarised the research on placebo effects in The Lancet.

According to the review, placebo effects are genuine psychobiological events that arise from the entire treatment context. They can be robust in the laboratory and in the clinic, even when no placebo is given at all.

What this means for you: if you feel better, you are not imagining it. Whether it is due to the remedy, to attention, to the ritual or to the natural course of things, only a fair comparison can show.

Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Lancet. 2010;375(9715):686-95. DOI: 10.1016/S0140-6736(09)61706-2

Kienle's team itself writes that randomisation and blinding were often rejected by anthroposophic doctors and their patients. That makes rigorous studies harder. MISTRAL shows that they are possible nonetheless.

It is also worth noting that the S3 guideline does not make blanket judgements. For a multimodal anthroposophic treatment programme with psychoeducation and sleep education, eurythmy therapy and painting therapy, it issues a “may” recommendation for fatigue and sleep disorders after breast cancer. For other anthroposophic treatments, it makes no recommendation for or against with regard to quality of life.

Four lenses on three plants

Mechanistically plausible means: there are understandable biological pathways, but no proof in humans yet. Through the KPNI lens, it looks like this.

Nervous system

Bryophyllum is used for restlessness and sleep disorders, and in one observational study, sleep quality improved. At the same time, placebo research shows how strongly expectation and attention can change how we experience things.

Immune system

Mistletoe extracts can trigger visible immune reactions, from reddened skin to more eosinophilic granulocytes in the blood. In the lab, arnica constituents slowed the inflammation switch NF-kappaB. Whether a benefit results from this is a separate question in each case.

Metabolism

Plants are small chemical factories. Bryophyllum contains bufadienolides, arnica contains sesquiterpene lactones. Both groups of substances are biologically active, and that is exactly why the amount matters: plenty in an extract, a vanishingly small amount in a high potency.

Hormonal system

In obstetrics, bryophyllum was tested against preterm labour, that is, against muscular work of the uterus that is strongly governed by hormones. Both randomised trials were stopped early. Hormonal phases of life such as pregnancy therefore call for particular caution.

What is established, and what is not?

Here I separate what studies in humans show, what is mechanistically plausible and what rests mainly on tradition and experience.

Assessment based on the sources cited in this article, as of October 2026.
UseFormEvidenceMy assessment
Mistletoe in cancer: survivalInjection under the skinContradictory reviews; double-blind RCT without benefit; S3 guideline: no recommendation for or againstDo not pin hopes of survival on it; never a substitute for cancer treatment
Mistletoe in cancer: quality of lifeInjection under the skinHeterogeneous studies; S3 guideline: may be considered (recommendation grade 0); MISTRAL without benefitA complementary option, only together with the oncology team
Arnica, externalGel, ointment, tinctureOne RCT similar to ibuprofen gel; Cochrane: moderate quality; EU monograph: traditional usePlausible for a few days for bruises; watch out for allergy
Arnica, potentisedGlobules, dropsSystematic review without proof of effect; meta-analysis: small, non-significant effectA matter of experience, no established effect
BryophyllumTablets made from pressed leaf juiceSmall, mostly uncontrolled studies; one small RCT with a trend; S3 guideline: insufficient dataOpen question, good studies are lacking
CalendulaCream, ointmentTwo RCTs on the skin during radiotherapy with opposite resultsSkincare yes, keep expectations realistic
A change of perspective

Experience is not the opponent of evidence. It is often the beginning of a good research question.

It only becomes difficult when experience is supposed to replace testing. Or when a lack of proof is hastily read as proof of ineffectiveness.

Freedom in medicine does not mean trying everything. It means choosing with your eyes open: with respect for your experience and with all the numbers on the table.

I also show you how to read studies on medicinal plants in general in Adaptogens explained. You can find a similarly critical look at another popular topic in Detox regimes under scrutiny.

And now you know why your experience counts and is still no substitute for a fair comparison.

Three levers if you want to use anthroposophic remedies

You do not have to pick a camp. You can take a targeted approach. These three steps are not a therapy, but a sequence I consider sensible.

1

Clarify form and status

For every remedy, ask: plant extract, potency or injection? And does the pack state an indication or the note on registration? These two questions place almost any preparation.

2

Everything on one list

Write every anthroposophic remedy on your medication list, including globules and ointments. If you have cancer, are pregnant or have an allergy to the daisy family, discuss it with a doctor beforehand, and with cancer always with your oncology team.

3

Observe your experience honestly

Decide in advance how you would recognise a benefit, for example in your sleep or your pain. If nothing changes after an agreed period, that is important information. Never give up an established treatment for it.

Self-check: when should you talk to a doctor before taking an anthroposophic remedy?

  • You have cancer or are receiving cancer treatment.
  • You are pregnant, planning a pregnancy or breastfeeding.
  • You have had an allergic reaction to chamomile, arnica, marigold or other daisy-family plants before.
  • A remedy is to be given to you by injection.
  • You take other medicines regularly.
  • Your symptoms persist, are getting worse, or are new and unexplained.

If you nod at one of these points, that is no reason to worry. It is a good reason for a conversation before you start a remedy. How carefully even plants should be weighed up during pregnancy is shown by the example of Ginger for nausea in pregnancy.

And now you know why the most respectful way to approach anthroposophic medicinal plants is an honest one.

Frequently asked questions about anthroposophic medicinal plants

What are anthroposophic medicinal plants?

The term refers to plants from which medicines are developed according to the anthroposophic understanding of the human being and nature. Well-known examples are mistletoe, arnica, bryophyllum and calendula. Depending on the remedy, they are made into plant extracts, fermented extracts or potencies, manufactured using homeopathic or special anthroposophic procedures. The label anthroposophic alone does not tell you whether a remedy is effective. That has to be assessed separately for each remedy and each use.

How do anthroposophic medicines differ from homeopathy and herbal medicine?

The difference lies mainly in the way of thinking and in manufacturing. Herbal medicine mostly uses extracts with measurable amounts of constituents, while homeopathic remedies are potentised using homeopathic procedures. Anthroposophic medicines can be an extract or a potency and may additionally use special anthroposophic manufacturing procedures. According to the German Medicinal Products Act, what matters is that they are developed and used according to the anthroposophic understanding of the human being and nature. In Germany, all three are classed as special therapeutic systems, each with its own commission at the Federal Institute for Drugs and Medical Devices.

Does mistletoe therapy replace cancer treatment?

No. Mistletoe therapy is not a cancer treatment and replaces neither surgery nor chemotherapy, radiotherapy, hormone therapy or immunotherapy. There is no robust evidence of longer survival, and the S3 guideline on complementary medicine in oncology makes no recommendation for or against it on this point. If anything, mistletoe can be a complementary use alongside your treatment. This decision belongs in a discussion with your treating oncology team.

What does the S3 guideline say about mistletoe therapy?

The German S3 guideline on complementary medicine in the treatment of cancer patients, version 2.0 from May 2024, distinguishes between two goals. On survival, it sees mixed results that are not sufficient for a final assessment, and it makes no recommendation for or against mistletoe preparations. On quality of life, it states that subcutaneous administration of whole mistletoe extract may be considered in solid tumours. This is an open “may” recommendation, the weakest grade of recommendation. The double-blind MISTRAL trial, which found no benefit, is probably not yet taken into account in it.

Can mistletoe improve quality of life in cancer?

The data are contradictory. A meta-analysis from Berlin found a medium-sized effect on global quality of life, but most of the included studies had a high risk of bias or gave cause for concern. A systematic review from Jena found less or no effect in methodologically better studies. In the double-blind MISTRAL trial with 290 people with advanced pancreatic cancer, there was no difference from placebo. A benefit in individual situations is possible, but it is not established.

What side effects does mistletoe therapy have?

Redness and swelling at the injection site and a slightly raised temperature are common. In the MISTRAL trial, 66 percent of the mistletoe group had skin reactions at the injection site, compared with 1 percent on placebo. In a Berlin observational study with 1,923 people, adverse effects occurred in 8.4 percent, mostly mild to moderate and with no serious cases. Rare whole-body allergic reactions, up to and including anaphylaxis, have been described. If you have shortness of breath, circulatory problems or swelling of the face, call the emergency number 112 immediately.

Does arnica gel make sense for bruises and osteoarthritis?

The best data exist for external use. In a double-blind study with 204 people with finger osteoarthritis, a gel made from arnica tincture performed similarly to an ibuprofen gel. The European Medicines Agency classifies arnica flowers as a traditional herbal medicinal product for bruises, sprains and localised muscle pain, from the age of twelve. If symptoms last longer than three to four days or get worse, it is advisable to seek medical advice. If you are allergic to the daisy family, you should avoid arnica.

What do studies show about arnica globules?

For potentised arnica, there is no established effect beyond placebo. In 1998, a systematic review from Exeter found mostly serious methodological flaws and no convincing benefit in eight placebo-controlled trials. In 2021, a meta-analysis from Witten/Herdecke found a small effect in placebo-controlled trials around surgery, which narrowly missed statistical significance. If arnica globules do you good, that is your experience. But with severe pain, marked swelling or a suspected fracture, you should not rely on them.

What does “Registered homeopathic medicinal product, therefore without stating a therapeutic indication” mean?

Section 10 of the German Medicinal Products Act prescribes this sentence for remedies in the register of homeopathic medicinal products. This can also include anthroposophic preparations manufactured using homeopathic procedures. For registration, no information on effects and indications and no clinical trials have to be submitted. So the sentence does not mean that a remedy is ineffective. It means that its efficacy has not been officially assessed.

What is Commission C?

Commission C is an expert commission for anthroposophic medicines at Germany's Federal Institute for Drugs and Medical Devices. Alongside it, there is Commission D for homeopathic and Commission E for herbal medicines. The Medicinal Products Act provides for the responsible commission to be involved in certain decisions on medicines of its therapeutic system. In this way, expertise from each system feeds into the authority's work.

What is bryophyllum, and what is it used for?

Bryophyllum pinnatum, also called Kalanchoe pinnata, is a succulent from Madagascar that has been used in anthroposophic medicine since the early 20th century. It is mainly used for restlessness and sleep disorders, and it has also been studied in obstetrics. The studies are mostly small and without a control group, and a small placebo-controlled trial in overactive bladder showed only a trend. The plant contains bufadienolides, which can be potentially toxic. So only use it after expert advice, and in pregnancy only under medical supervision or together with your midwife.

Are anthroposophic medicines safe?

According to the available data, serious side effects are rare. In an analysis covering 44,662 patients and over 311,000 prescriptions, side effects occurred in 0.071 percent of prescriptions, counted among doctors who documented all reactions. In reporting databases, injections stood out more often than tablets or external remedies. Allergies to daisy-family plants such as arnica, calendula or chamomile are possible. The large safety analyses come mainly from institutions close to anthroposophic medicine, and independent data would be desirable.

Can I take anthroposophic remedies during pregnancy?

There is no blanket answer. For the remedies discussed here, I found hardly any systematic safety studies on pregnancy and breastfeeding. Bryophyllum contains bufadienolides, which can be potentially toxic, and the studies on suppressing preterm contractions were stopped early. So during pregnancy, do not take any remedy on your own initiative, but talk to your gynaecologist or your midwife. With preterm labour, you belong in a maternity hospital.

Where else this topic comes into play

Joints, sleep, allergies and a critical look at popular remedies are cross-cutting topics. These articles approach them from other directions.

SJ

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

In my private practice in Berlin, I work at the intersection of conventional medicine, functional medicine and Clinical Psychoneuroimmunology. For me, anthroposophic medicines are one building block among others, alongside lifestyle, diagnostics and targeted therapy.

With medicinal plants, I am interested in both: what they might do in the body and where their limits lie. I try to consistently separate what studies demonstrate, what is mechanistically plausible and what rests on tradition and experience.

Private practice Shukri Jarmoukli · ViveCura · Skalitzer Straße 137, 10999 Berlin · vivecura.com

Scientific sources and documents

All studies were checked via PubMed for existence, authorship, journal, year and abstract content, and key DOI links were checked to confirm they resolve. Legal information comes from the German Medicinal Products Act in the version published on gesetze-im-internet.de, guideline statements from the short version 2.0 of the S3 guideline, and information on arnica flowers from the EU monograph. The study type is given in square brackets so that you can judge the robustness for yourself.

  1. Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in europe. Glob Adv Health Med. 2013;2(6):20-31. DOI: 10.7453/gahmj.2012.087 [Review, foundations and state of research]
  2. German Medicinal Products Act (Gesetz über den Verkehr mit Arzneimitteln, Arzneimittelgesetz, AMG), in particular § 4(26) and (33), § 10(4), § 22(3), § 25(2) and (7), §§ 38 and 39. Accessed 31 October 2026. gesetze-im-internet.de [Regulatory document, statutory text]
  3. Kienle GS, Glockmann A, Grugel R, Hamre HJ, Kiene H. Clinical research on anthroposophic medicine: update of a health technology assessment report and status quo. Forsch Komplementmed. 2011;18(5):269-82. DOI: 10.1159/000331812 [Systematic review, HTA update, 265 studies]
  4. Ernst E. Anthroposophical medicine: a systematic review of randomised clinical trials. Wien Klin Wochenschr. 2004;116(4):128-30. DOI: 10.1007/BF03040749 [Systematic review, whole system, no eligible study found]
  5. Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM). Complementary and Alternative Medicines (CAM) and Traditional Medicinal Products (TMP): Commissions C, D and E. Accessed 31 October 2026. bfarm.de [Regulatory document]
  6. German Guideline Program in Oncology (Leitlinienprogramm Onkologie: German Cancer Society, German Cancer Aid, AWMF): S3 guideline Complementary Medicine in the Treatment of Oncological Patients (S3-Leitlinie Komplementärmedizin in der Behandlung von onkologischen PatientInnen), short version 2.0, 2024, AWMF registry number 032-055OL. Statements and recommendations 4.21, 4.22, 4.24, 7.69 and 7.70. leitlinienprogramm-onkologie.de [Systematic review with structured consensus, S3 guideline]
  7. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008;(2):CD003297. DOI: 10.1002/14651858.CD003297.pub2 [Systematic review, 21 RCTs, n=3,484]
  8. Ernst E, Schmidt K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer. 2003;107(2):262-7. DOI: 10.1002/ijc.11386 [Systematic review, 10 RCTs]
  9. Freuding M, Keinki C, Micke O, Buentzel J, Huebner J. Mistletoe in oncological treatment: a systematic review. Part 1: survival and safety. J Cancer Res Clin Oncol. 2019;145(3):695-707. DOI: 10.1007/s00432-018-02837-4 [Systematic review, 28 publications, n=2,639]
  10. Freuding M, Keinki C, Kutschan S, Micke O, Buentzel J, Huebner J. Mistletoe in oncological treatment: a systematic review. Part 2: quality of life and toxicity of cancer treatment. J Cancer Res Clin Oncol. 2019;145(4):927-939. DOI: 10.1007/s00432-018-02838-3 [Systematic review, quality of life]
  11. Loef M, Walach H. Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis. BMC Complement Med Ther. 2020;20(1):227. DOI: 10.1186/s12906-020-03013-3 [Meta-analysis, 26 publications, 30 data sets]
  12. Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C, Büssing A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement Med Res. 2020;27(4):260-271. DOI: 10.1159/000505202 [Meta-analysis, 32 studies with survival data, none blinded]
  13. Loef M, Walach H. Survival of Cancer Patients Treated with Non-Fermented Mistletoe Extract: A Systematic Review and Meta-Analysis. Integr Cancer Ther. 2022;21:15347354221133561. DOI: 10.1177/15347354221133561 [Meta-analysis, 11 RCTs and 8 non-randomised studies]
  14. Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M. Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Dtsch Arztebl Int. 2014;111(29-30):493-502. DOI: 10.3238/arztebl.2014.0493 [RCT, open-label, n=220]
  15. Wode K, Kienle GS, Björ O, et al. Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Trial (MISTRAL). Dtsch Arztebl Int. 2024;121(11):347-354. DOI: 10.3238/arztebl.m2024.0080 [RCT, double-blind, placebo-controlled, n=290]
  16. Wode K, Björ O, Klein R, et al. Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL). Palliat Med. 2026;40(7):1059-1076. DOI: 10.1177/02692163261437609 [RCT, double-blind, n=290, quality of life and biomarkers]
  17. Steele ML, Axtner J, Happe A, Kröz M, Matthes H, Schad F. Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients. Evid Based Complement Alternat Med. 2014;2014:724258. DOI: 10.1155/2014/724258 [Cohort, multicentre observational study, n=1,923]
  18. Casetti F, Rafei-Shamsabadi D, Müller S. Grade II-anaphylaxis after subcutaneous injection of mistletoe extract. Contact Dermatitis. 2021;85(4):462-465. DOI: 10.1111/cod.13880 [Case, case report]
  19. Widrig R, Suter A, Saller R, Melzer J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study. Rheumatol Int. 2007;27(6):585-91. DOI: 10.1007/s00296-007-0304-y [RCT, double-blind, n=204]
  20. Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2013;(5):CD010538. DOI: 10.1002/14651858.CD010538 [Systematic review, 7 RCTs, n=785]
  21. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Final Community herbal monograph on Arnica montana L., flos. EMA/HMPC/198793/2012. Published 22 July 2014. ema.europa.eu [Regulatory document, EU monograph on arnica flowers]
  22. Klaas CA, Wagner G, Laufer S, et al. Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers. Planta Med. 2002;68(5):385-91. DOI: 10.1055/s-2002-32067 [In vitro, human immune cells, and in vivo, mouse]
  23. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem. 1998;273(50):33508-16. DOI: 10.1074/jbc.273.50.33508 [In vitro, cell line]
  24. Ernst E, Pittler MH. Efficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials. Arch Surg. 1998;133(11):1187-90. DOI: 10.1001/archsurg.133.11.1187 [Systematic review, 8 placebo-controlled trials]
  25. Gaertner K, Baumgartner S, Walach H. Is Homeopathic Arnica Effective for Postoperative Recovery? A Meta-analysis of Placebo-Controlled and Active Comparator Trials. Front Surg. 2021;8:680930. DOI: 10.3389/fsurg.2021.680930 [Meta-analysis, 23 publications, 28 comparisons]
  26. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis. 2002;47(4):189-98. DOI: 10.1034/j.1600-0536.2002.470401.x [Review, contact allergy to the daisy family]
  27. Fürer K, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and Related Species Used in Anthroposophic Medicine: Constituents, Pharmacological Activities, and Clinical Efficacy. Planta Med. 2016;82(11-12):930-41. DOI: 10.1055/s-0042-106727 [Review]
  28. Simões-Wüst AP, Hassani TA, Müller-Hübenthal B, et al. Sleep Quality Improves During Treatment With Bryophyllum pinnatum: An Observational Study on Cancer Patients. Integr Cancer Ther. 2015;14(5):452-9. DOI: 10.1177/1534735415580680 [Cohort, prospective observational study, n=20 analysed]
  29. Betschart C, von Mandach U, Seifert B, et al. Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine. 2013;20(3-4):351-8. DOI: 10.1016/j.phymed.2012.10.007 [RCT, double-blind, n=20]
  30. Bachmann S, Betschart C, Gerber J, et al. Potential of Bryophyllum pinnatum as a Detrusor Relaxant: An in Vitro Exploratory Study. Planta Med. 2017;83(16):1274-1280. DOI: 10.1055/s-0043-109097 [In vitro, pig bladder muscle]
  31. Simões-Wüst AP, Lapaire O, Hösli I, et al. Two Randomised Clinical Trials on the Use of Bryophyllum pinnatum in Preterm Labour: Results after Early Discontinuation. Complement Med Res. 2018;25(4):269-273. DOI: 10.1159/000487431 [RCT, two trials, stopped early]
  32. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22(8):1447-53. DOI: 10.1200/JCO.2004.07.063 [RCT, n=254]
  33. Sharp L, Finnilä K, Johansson H, Abrahamsson M, Hatschek T, Bergenmar M. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions: results from a randomised blinded trial. Eur J Oncol Nurs. 2013;17(4):429-35. DOI: 10.1016/j.ejon.2012.11.003 [RCT, blinded, n=420]
  34. Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network. Drugs Real World Outcomes. 2017;4(4):199-213. DOI: 10.1007/s40801-017-0118-5 [Cohort, prospective pharmacovigilance, n=44,662]
  35. Jong MC, van Wietmarschen H, Glockmann A, Baars EW, Hamre HJ. Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases. Drugs Real World Outcomes. 2021;8(4):589-601. DOI: 10.1007/s40801-021-00262-7 [Real-world, spontaneous reports from four manufacturers]
  36. Jeschke E, Ostermann T, Lüke C, et al. Remedies containing Asteraceae extracts: a prospective observational study of prescribing patterns and adverse drug reactions in German primary care. Drug Saf. 2009;32(8):691-706. DOI: 10.2165/00002018-200932080-00007 [Cohort, prospective observational study, n=50,115]
  37. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686-95. DOI: 10.1016/S0140-6736(09)61706-2 [Review, placebo research]

Transparency on the evidence. For mistletoe, there are numerous randomised trials and reviews whose results partly contradict each other; many trials were not blinded. For arnica, bryophyllum and calendula, the evidence consists mainly of small studies, individual randomised comparisons, observational data and laboratory and animal experiments. Mechanisms from cell and animal experiments are biologically plausible but not conclusively demonstrated in humans. The large safety analyses come mainly from institutions close to anthroposophic medicine. Legal information reflects the statutory texts at the time of research and is no substitute for legal advice.

No substitute for medical advice. This article is for information only and does not replace an individual examination, diagnosis or treatment. The figures mentioned come from studies and monographs and are not dosage recommendations. Mistletoe therapy in cancer is not a cancer treatment and should only be used in consultation with the treating oncology team. Anyone who is pregnant, breastfeeding, taking medication or allergic to the daisy family should discuss anthroposophic medicines with a doctor beforehand. An existing treatment should never be reduced or stopped on your own initiative.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment